Alethea Capital Management, LLC Portfolio Holdings

Alethea Capital Management, LLC

  • $138 Million
  • Q3 2024

Alethea Capital Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $138 Million distributed in 30 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Axsome Therapeutics, Inc. with a value of $66.4M, Spdr Bloomberg 1 3 Month T Bil with a value of $29.8M, Avidity Biosciences, Inc. with a value of $19.6M, Kura Oncology, Inc. with a value of $10.8M, and Ishares Barclays 20+ Year Trea with a value of $2.27M.

Examining the 13F form we can see an increase of $6.75M in the current position value, from $131M to 138M.

Alethea Capital Management, LLC is based out at San Diego, CA

Below you can find more details about Alethea Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $138 Million
Healthcare: $97.8 Million
ETFs: $32.4 Million
Consumer Cyclical: $1.63 Million
Industrials: $1.61 Million
Consumer Defensive: $1.49 Million
Communication Services: $831,000
Financial Services: $587,000
Real Estate: $446,000
Other: $806,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$4.06B
$66.4 Million 48.23% of portfolio
738,503
Q3 2024 Reduced 0.32%
$0
$29.8 Million 21.63% of portfolio
324,107
Q3 2024 Reduced 9.98%
$2.28B
$19.6 Million 14.27% of portfolio
427,454
Q3 2024 Reduced 15.1%
$1.06B
$10.8 Million 7.86% of portfolio
553,542
Q3 2024 Added 108.17%
$0
$2.27 Million 1.65% of portfolio
23,123
Q1 2024 Reduced 0.67%
$8.54B
$457,000 0.33% of portfolio
6,324
Q3 2024 New
$214B
$443,000 0.32% of portfolio
1,457
Q3 2024 Reduced 20.3%
$22.7B
$446,000 0.32% of portfolio
13,191
Q3 2024 New
$57.2B
$428,000 0.31% of portfolio
5,518
Q3 2024 New
$38.5B
$428,000 0.31% of portfolio
10,575
Q3 2024 New
$112B
$424,000 0.31% of portfolio
4,714
Q3 2024 New
$20.2B
$425,000 0.31% of portfolio
4,120
Q3 2024 New
$16.4B
$415,000 0.3% of portfolio
10,940
Q3 2024 New
$41.2B
$417,000 0.3% of portfolio
7,284
Q3 2024 New
$82B
$412,000 0.3% of portfolio
1,868
Q3 2024 New
$11B
$406,000 0.3% of portfolio
12,847
Q3 2024 New
$19B
$400,000 0.29% of portfolio
1,381
Q3 2024 New
$16.5B
$378,000 0.27% of portfolio
11,949
Q3 2024 New
$30.9B
$378,000 0.27% of portfolio
6,934
Q3 2024 New
$17B
$377,000 0.27% of portfolio
2,700
Q3 2024 New
$12.6B
$364,000 0.26% of portfolio
3,305
Q3 2024 New
$0
$360,000 0.26% of portfolio
8,020
Q3 2023 Added 100.0%
$19.3B
$347,000 0.25% of portfolio
4,220
Q3 2024 New
$10.1B
$350,000 0.25% of portfolio
8,785
Q3 2024 New
$15.1B
$345,000 0.25% of portfolio
3,462
Q3 2024 New
$45.8M
$151,000 0.11% of portfolio
128,448
Q1 2024 Reduced 3.99%
$0
$102,000 0.07% of portfolio
10,658
Q3 2023 Reduced 18.82%
$786M
$73,000 0.05% of portfolio
12,000
Q3 2021 Reduced 14.29%
Cidara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 New

Summary

  • Portfolio
  • No. of Stocks 30
  • Current Value $138 Million
  • Prior Value $131 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 19 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Alethea Capital Management, LLC Portfolio

Follow Alethea Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alethea Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alethea Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email